Sarissa Capital Management as of Sept. 30, 2024
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Innoviva (INVA) | 34.9 | $141M | 7.3M | 19.31 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.8 | $68M | 16M | 4.12 | |
| Gilead Sciences (GILD) | 15.9 | $64M | 763k | 83.84 | |
| Cytokinetics Com New (CYTK) | 14.6 | $59M | 1.1M | 52.80 | |
| Neurocrine Biosciences (NBIX) | 11.8 | $47M | 411k | 115.22 | |
| Amarin Corp Spons Adr New (AMRN) | 3.9 | $16M | 25M | 0.63 | |
| Biogen Idec (BIIB) | 1.3 | $5.2M | 27k | 193.84 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $2.9M | 26k | 109.75 | |
| Vor Biopharma (VOR) | 0.1 | $433k | 618k | 0.70 | |
| Regulus Therapeutics (RGLS) | 0.1 | $291k | 185k | 1.57 |
